Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.45 USD | -0.55% | +9.66% | -30.04% |
05-14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Syros Pharmaceuticals, Inc. Agrees to Amend Its Loan Agreement with Oxford Finance LLC | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SYROS PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | -0.55% | +9.66% | -30.04% | +33.58% | -91.89% | 146M |
Technical Rankings Surperformance
- Stock Market
- Equities
- SYRS Stock
- Charts Syros Pharmaceuticals, Inc.
- Comparison Chart